JP2012511506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511506A5 JP2012511506A5 JP2011539029A JP2011539029A JP2012511506A5 JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5 JP 2011539029 A JP2011539029 A JP 2011539029A JP 2011539029 A JP2011539029 A JP 2011539029A JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5
- Authority
- JP
- Japan
- Prior art keywords
- human insulin
- desb30
- insulin
- amino acid
- analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 85
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims 85
- 101150019032 B29R gene Proteins 0.000 claims 15
- 239000004026 insulin derivative Substances 0.000 claims 15
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 14
- 125000000539 amino acid group Chemical group 0.000 claims 12
- 102200082905 rs35203747 Human genes 0.000 claims 10
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 229940125396 insulin Drugs 0.000 claims 2
- 108700004929 A8H,B25N,B27E,desB30- insulin Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 102220092852 rs754853086 Human genes 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08171086 | 2008-12-09 | ||
| EP08171086.5 | 2008-12-09 | ||
| EPPCT/EP2009/053017 | 2009-03-13 | ||
| PCT/EP2009/053017 WO2009115469A1 (en) | 2008-03-18 | 2009-03-13 | Protease stabilized, acylated insulin analogues |
| EP09161014 | 2009-05-25 | ||
| EP09161014.7 | 2009-05-25 | ||
| EP09161232 | 2009-05-27 | ||
| EP09161232.5 | 2009-05-27 | ||
| PCT/EP2009/066335 WO2010066636A1 (en) | 2008-12-09 | 2009-12-03 | Novel insulin analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012511506A JP2012511506A (ja) | 2012-05-24 |
| JP2012511506A5 true JP2012511506A5 (enExample) | 2014-06-19 |
Family
ID=41651437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539029A Withdrawn JP2012511506A (ja) | 2008-12-09 | 2009-12-03 | 新規インスリンアナログ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110294729A1 (enExample) |
| EP (1) | EP2376531A1 (enExample) |
| JP (1) | JP2012511506A (enExample) |
| CN (1) | CN102245633A (enExample) |
| WO (1) | WO2010066636A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2254906T3 (en) | 2008-03-18 | 2017-01-23 | Novo Nordisk As | Protease-stabilized acylated insulin analogues |
| CN102947331B (zh) * | 2010-06-23 | 2016-08-03 | 诺沃—诺迪斯克有限公司 | 包含额外的二硫键的胰岛素类似物 |
| AU2011269000C1 (en) | 2010-06-23 | 2015-10-08 | Novo Nordisk A/S | Insulin derivatives containing additional disulfide bonds |
| EP2585483A1 (en) | 2010-06-23 | 2013-05-01 | Novo Nordisk A/S | Human insulin containing additional disulfide bonds |
| CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
| EP2901154B1 (en) * | 2012-09-25 | 2018-11-21 | The Walter and Eliza Hall Institute of Medical Research | Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain |
| US20140269611A1 (en) * | 2013-03-14 | 2014-09-18 | T-Mobile Usa, Inc. | Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks |
| IL264330B2 (en) * | 2016-07-22 | 2024-05-01 | Univ Utah Res Found | An insulin analog, pharmaceutical composition comprising it and its uses |
| HUE060149T2 (hu) | 2016-12-16 | 2023-02-28 | Novo Nordisk As | Inzulint tartalmazó gyógyászati készítmények |
| CA3122636A1 (en) | 2018-12-11 | 2020-06-18 | Sanofi | Insulin analogs having reduced insulin receptor binding affinity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU616205B2 (en) * | 1988-07-20 | 1991-10-24 | Novo Nordisk A/S | Human insulin analogs and preparations containing them |
| US5716927A (en) * | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
| ATE120762T1 (de) * | 1989-04-20 | 1995-04-15 | Sinai School Medicine | Hepatospezifische insulin-analoga. |
| US5268453A (en) * | 1991-08-08 | 1993-12-07 | Scios Inc. | Tissue-selective insulin analogs |
| JP2003518917A (ja) * | 1999-05-19 | 2003-06-17 | ゼンコー | 糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質 |
| US6746853B1 (en) * | 1999-05-19 | 2004-06-08 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| ES2601839T3 (es) * | 2006-09-22 | 2017-02-16 | Novo Nordisk A/S | Análogos de insulina resistentes a proteasas |
| EP2254905B1 (en) * | 2008-03-14 | 2016-12-14 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| DK2254906T3 (en) * | 2008-03-18 | 2017-01-23 | Novo Nordisk As | Protease-stabilized acylated insulin analogues |
-
2009
- 2009-12-03 US US13/133,465 patent/US20110294729A1/en not_active Abandoned
- 2009-12-03 EP EP09771326A patent/EP2376531A1/en not_active Withdrawn
- 2009-12-03 WO PCT/EP2009/066335 patent/WO2010066636A1/en not_active Ceased
- 2009-12-03 CN CN2009801494190A patent/CN102245633A/zh not_active Withdrawn
- 2009-12-03 JP JP2011539029A patent/JP2012511506A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511506A5 (enExample) | ||
| JP2018527288A5 (enExample) | ||
| WO2014071405A3 (en) | Long-acting single-chain insulin analogues | |
| WO2010014946A3 (en) | Halogen-stabilized insulin | |
| JP2013530974A5 (enExample) | ||
| EP2717918C0 (en) | COMPOSITION FOR THE TREATMENT OF DIABETES COMPRISING A LONG-ACTING INSULIN CONJUGATE AND A LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | |
| JP2018505146A5 (enExample) | ||
| JP2014129355A5 (enExample) | ||
| JP2013533227A5 (enExample) | ||
| WO2009112583A3 (en) | Protease-stabilized insulin analogues | |
| EP2543727A4 (en) | MODIFIED ANTIBODY COMPOSITION | |
| MY167234A (en) | Novel glucagon analogues | |
| PH12012501135A1 (en) | Insulin analogues with chlorinated amino acids | |
| WO2015128403A3 (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue | |
| JP2013530702A5 (enExample) | ||
| NZ597676A (en) | Crystalline anti-hTNFalpha antibodies | |
| JP2017500289A5 (enExample) | ||
| HK1213483A1 (zh) | Glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂 | |
| MX2013011175A (es) | Analogos de glucagon novedosos. | |
| JP2013542919A5 (enExample) | ||
| EP2570873A3 (en) | Watch with shapeable strap | |
| WO2010010551A3 (en) | Angiopoietin derived peptides | |
| WO2011072288A3 (en) | Insulin analogues with chlorinated amino acids | |
| WO2011143406A3 (en) | Parathyroid hormone analogs and uses thereof | |
| WO2016105545A3 (en) | Insulin analogues with enhanced stabilized and reduced mitogenicity |